Henry Ford Hospital Medical Journal


This report of the beneficial response in central nervous system (CNS) manifestations of a patient with Hodgkin's disease to the intrathecal administration of cytosine arabinoside suggests that this drug may have value in the treatment of CNS involvement by lymphoma and acute leukemia and of some brain tumors. Its use, for the first time via the intrathecal route in the present case, was well tolerated in two series of treatments.



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.